January 2, 2026

Celcuity Inc. (CELC) Stock Report: A Biotechnology Pioneer with a 10.79% Potential Upside

Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company headquartered in Minneapolis, is making waves in the healthcare sector with its innovative approach to cancer treatment. Primarily focused on developing targeted..

Standard BioTools Inc. (LAB) Stock Analysis: Exploring a Potential 21% Upside in the Medical Devices Sector

Standard BioTools Inc. (NASDAQ: LAB) operates at the forefront of the healthcare sector, specializing in the development and sale of sophisticated instrumentation, consumables, and services for biomedical research. The company’s..

Castle Biosciences, Inc. (CSTL) Stock Analysis: A Healthcare Innovator with Strong Buy Ratings and Promising Target Price

Castle Biosciences, Inc. (NASDAQ: CSTL) is making waves in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $1.14 billion, this molecular diagnostics company..

Bicycle Therapeutics plc (BCYC) Stock Analysis: Exploring the 203% Upside Potential in Biotechnology

Bicycle Therapeutics plc (NASDAQ: BCYC), a UK-based biotechnology firm, is capturing investor attention with a staggering potential upside of 203.67%. This figure, combined with the company’s innovative approach in developing..

Upstream Bio, Inc. (UPB) Stock Analysis: Biotech Innovator with a 75% Potential Upside

Upstream Bio, Inc. (UPB) has emerged as a promising player in the biotechnology sector, particularly within the niche of inflammatory disease treatments. With its focus on severe respiratory disorders, this..

Personalis, Inc. (PSNL) Stock Analysis: Exploring a 38% Upside Potential in the Healthcare Diagnostics Sector

Investors with an eye on the healthcare diagnostics sector might find Personalis, Inc. (NASDAQ: PSNL) an intriguing opportunity, especially given the significant 38.19% potential upside based on current analyst ratings...

Surmodics, Inc. (SRDX) Stock Report: Navigating Challenges with Innovative Medical Solutions

Surmodics, Inc. (NASDAQ: SRDX), a key player in the healthcare sector specializing in medical devices, is certainly an intriguing entity for investors with a penchant for innovation-driven growth. Based in..

REGENXBIO Inc. (RGNX) Investor Outlook: Exploring a 110.86% Upside Potential in Gene Therapy Innovation

REGENXBIO Inc. (NASDAQ: RGNX) stands out in the biotechnology sector with its innovative approach to gene therapy, particularly through its proprietary NAV Technology Platform. This clinical-stage company, headquartered in Rockville,..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: Exploring a 99.97% Potential Upside

ArriVent BioPharma, Inc. (AVBP), a burgeoning player in the biotechnology sector, is capturing investor attention with its promising pipeline and a staggering potential upside of 99.97%. A clinical-stage biopharmaceutical firm,..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring a 115% Potential Upside Amidst Market Challenges

Investors with an eye on the healthcare sector may find Treace Medical Concepts, Inc. (NASDAQ: TMCI) a compelling yet challenging opportunity. As a player in the medical device industry, the..

CeriBell, Inc. (CBLL) Stock Analysis: Unpacking a 28.33% Potential Upside in the Medical Device Arena

CeriBell, Inc. (CBLL), a healthcare company specializing in medical devices, is drawing significant investor attention. With a market capitalization of $813.51 million, CeriBell is positioning itself as a disruptive force..

Oruka Therapeutics, Inc. (ORKA) Investor Outlook: 63% Upside Potential Sparks Interest in Biotech Innovator

Oruka Therapeutics, Inc. (ORKA), a clinical-stage biopharmaceutical company headquartered in Menlo Park, California, is capturing attention in the healthcare sector with its promising pipeline of monoclonal antibody therapeutics. Specializing in..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Exploring a 42.78% Upside Potential in the Biotech Sector

Theravance Biopharma, Inc. (NASDAQ: TBPH) is emerging as a compelling opportunity for investors seeking exposure in the biotechnology sector. With a market capitalization of $948.08 million and a promising product..

Iovance Biotherapeutics, Inc. (IOVA) Stock Report: Exploring a Potential 205% Upside Amidst Biotech Innovations

Investors are keeping a keen eye on Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotech firm with a market capitalization of $1.08 billion, as it navigates the dynamic landscape of cancer..

Tectonic Therapeutic (TECX) Stock Analysis: Unveiling a 277% Upside Potential in Biotech Innovation

Tectonic Therapeutic, Inc. (NASDAQ: TECX) is capturing investor attention with an eye-catching potential upside of 277.35%, according to consensus analyst ratings. As a promising player in the biotechnology sector, the..

Verastem, Inc. (VSTM) Investor Outlook: Exploring a Potential 107% Upside in the Biotech Sector

Verastem, Inc. (NASDAQ: VSTM), a biopharmaceutical company dedicated to the development and commercialization of cancer treatments, has been capturing investor attention with its robust pipeline and ambitious clinical programs. As..

Myriad Genetics, Inc. (MYGN): Investor Outlook Reveals 38% Upside Potential Amid Mixed Ratings

Investors eyeing the healthcare sector may find Myriad Genetics, Inc. (NASDAQ: MYGN) a compelling, albeit complex, opportunity in the diagnostics and research industry. With a current market capitalization of $573.26..

Evolus, Inc. (EOLS) Stock Analysis: Exploring a Potential 178% Upside in the Aesthetic Market

Evolus, Inc. (NASDAQ: EOLS) is garnering attention from investors as a promising player in the healthcare sector, specifically within the drug manufacturers specializing in specialty and generic products. Headquartered in..

Bioventus Inc. (BVS) Stock Analysis: Exploring a 101.61% Upside Potential in the Healthcare Sector

Individual investors looking to capitalize on potential growth opportunities in the healthcare sector may find Bioventus Inc. (NASDAQ: BVS) an intriguing prospect. With a focus on innovative medical devices aimed..

PureTech Health plc (PRTC) Stock Analysis: A Biotech Growth Story with 542.7% Revenue Surge

PureTech Health plc (NASDAQ: PRTC) stands out as a dynamic player in the biotechnology sector, leveraging its innovative approach to develop and commercialize transformative medical solutions. Based in Boston, Massachusetts,..

Search

Funds

January 2, 2026

Search

Funds

January 2, 2026

FTSE 100

Funds